FDA seeks more safety data on Vioxx successor Merck  amp; Co. said the US Food and Drug Administration has requested additional safety and efficacy information on its Vioxx successor, Arcoxia, before it considers granting US approval for the drug. 

Which section of a newspaper would this article likely appear in? 